Children's Oncology Group NCORP Research Base Grant
Official title: Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base Grant
Funded at Cog Research Foundation, LLC · NIH-11611306 · Data updated 2026-11-12
A pediatric cancer research program across many sites is testing better treatments and ways to reduce late effects for kids and young adults with cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cog Research Foundation, LLC NIH-funded |
| Lab location | 1 site (Arcadia, United States) |
| Project start | December 1, 2025 |
| Project end | July 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $5,963,191 |
| NIH project number | 4UG1CA189955-13 |
| Project ID | NIH-11611306 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are children and adolescents or young adults with cancer who are treated at or connected to participating NCORP sites and are eligible for current pediatric cancer trials.
✕Less likely to help
Patients not eligible for current trials or outside participating sites may not directly benefit from this grant.
What this research studies
This grant supports pediatric and adolescent and young adult cancer research through a network of community hospitals and cancer centers. It builds on the Children’s Oncology Group infrastructure to conduct clinical trials and laboratory studies that aim to improve treatments and lessen long-term side effects. The work involves collaboration across 47 sites, leveraging data management and IT capabilities to translate findings into practice. The focus is on optimizing therapies for childhood cancers and addressing survivorship issues that affect quality of life. The program seeks to bring innovative, evidence-based options to patients closer to home through community-based participation.
Why it matters
Potential benefit: If successful, this program could lead to more effective treatments with fewer long-term complications for children and young adults with cancer.
How similar studies have gone: Previous pediatric cooperative group trials have improved survival and informed standard-of-care changes, though some cancers still have high relapse rates.
Where this research is happening
-
Cog Research Foundation, LLC
Arcadia, United States Active
Researchers
- Principal investigator: Roth, Michael E. — Cog Research Foundation, LLC
- Study coordinator: Roth, Michael E.
Related research
Other NIH-funded projects on the same topics.
-
Pediatric Early Phase Clinical Trials Network transfer opportunity for kids with cancer
A national network aims to test new cancer therapies in children and adolescents, using genomics, biology, imaging, and patient-reported outcomes to understand how these treatments work in young patients.
-
COG’s Network Operations Center for pediatric cancer trials
A national network hub helps many children with cancer join cutting-edge clinical trials by supporting coordinating sites and standardizing study processes.
-
COG Network Operations Center for Pediatric and Adolescent Cancer Trials
A national pediatric and young adult cancer trials network is led to design and run cutting-edge, collaborative clinical studies that aim to improve outcomes for children and young patients with cancer.
-
COG Coordinating Center for Pediatric and Young Adult Cancer Research
A centralized leadership and operations hub supports pediatric and young adult cancer studies to accelerate better treatments and outcomes.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.